N.C. Gen. Stat. § 116-29.1
University Cancer Research Fund
Redline — June 1, 2021 → current.View current text →
Current — June 1, 2022
As of June 1, 2021
(1) Fund. - The University Cancer Research Fund is established as a special revenue fund in the Office of the President of The University of North Carolina. Allocations from the fund shall be made in the discretion of the Cancer Research Fund Committee and shall be used only for the purpose of cancer research under UNC Hospitals, the Lineberger Comprehensive Cancer Center, or both.
(1) Fund. — The University Cancer Research Fund is established as a special revenue fund in the Office of the President of The University of North Carolina. Allocations from the fund shall be made in the discretion of the Cancer Research Fund Committee and shall be used only for the purpose of cancer research under UNC Hospitals, the Lineberger Comprehensive Cancer Center, or both.
(2) Effective July 1 of each calendar year, the funds remitted to the University Cancer Research Fund by the Secretary of Revenue from the tax on tobacco products other than cigarettes pursuant to G.S. 105-113.40A are appropriated for this purpose.
(2) Effective July 1 of each calendar year, the funds remitted to the University Cancer Research Fund by the Secretary of Revenue from the tax on tobacco products other than cigarettes pursuant to G.S. 105-113.40 A are appropriated for this purpose.
(3) Cancer Research Fund Committee. — The Cancer Research Fund Committee shall consist of five ex officio members and two appointed members. The five ex officio members shall consist of the following: (i) one member shall be the Chancellor of the University of North Carolina at Chapel Hill, (ii) one member shall be the Director of the Lineberger Comprehensive Cancer Center, (iii) one member shall be the Dean of the School of Medicine at The University of North Carolina, (iv) one member shall be the Dean of the School of Pharmacy at The University of North Carolina, and (v) one member shall be the Dean of the School of Public Health at The University of North Carolina. The remaining two members shall be appointed by a majority vote of the standing members of the Committee and shall be selected from persons holding a leadership position in a nationally prominent cancer program.
(3) Cancer Research Fund Committee. — The Cancer Research Fund Committee shall consist of five ex officio members and two appointed members. The five ex officio members shall consist of the following: (i) one member shall be the Chancellor of the University of North Carolina at Chapel Hill, (ii) one member shall be the Director of the Lineberger Comprehensive Cancer Center, (iii) one member shall be the Dean of the School of Medicine at The University of North Carolina, (iv) one member shall be the Dean of the School of Pharmacy at The University of North Carolina, and (v) one member shall be the Dean of the School of Public Health at The University of North Carolina. The remaining two members shall be appointed by a majority vote of the standing members of the Committee and shall be selected from persons holding a leadership position in a nationally prominent cancer program.If any of the specified positions cease to exist, then the successor position shall be deemed to be substituted in the place of the former one, and the person holding the successor position shall become an ex officio member of the Committee.
(4) Chair. - The chair shall be the Chancellor of the University of North Carolina at Chapel Hill.
(4) Chair. — The chair shall be the Chancellor of the University of North Carolina at Chapel Hill.
(5) Quorum. - A majority of the members shall constitute a quorum for the transaction of business.
(5) Quorum. — A majority of the members shall constitute a quorum for the transaction of business.
(6) Meetings. - The Committee shall meet at least once in each quarter and may hold special meetings at any time and place at the call of the chair or upon the written request of at least a majority of its members.
(6) Meetings. — The Committee shall meet at least once in each quarter and may hold special meetings at any time and place at the call of the chair or upon the written request of at least a majority of its members.
(7) Report. - By November 1 of each year, the Cancer Research Fund Committee shall provide to the Joint Legislative Education Oversight Committee and to the Office of State Budget and Management an annual financial report which shall include the following components: Accounting of expenditures of State funds related to strategic initiatives, development of infrastructure, and ongoing administrative functions.
(7) Report. — By November 1 of each year, the Cancer Research Fund Committee shall provide to the Joint Legislative Education Oversight Committee and to the Office of State Budget and Management an annual financial report which shall include the following components: Accounting of expenditures of State funds related to strategic initiatives, development of infrastructure, and ongoing administrative functions.
(8) Accounting of expenditures of extramural funds related to strategic initiatives, development of infrastructure, and ongoing administrative functions.
(8) Accounting of expenditures of extramural funds related to strategic initiatives, development of infrastructure, and ongoing administrative functions.
(9) Measures of impact to the State's economy in the creation of jobs, intellectual property, and start-up companies.
(9) Measures of impact to the State’s economy in the creation of jobs, intellectual property, and start-up companies.
(10) Other performance measures directly related to the investment of State funds.
(10) Other performance measures directly related to the investment of State funds.
(11) Accounting of any fund balances retained by the Fund, along with information about any restrictions on the use of these funds.
(11) Accounting of any fund balances retained by the Fund, along with information about any restrictions on the use of these funds.
If any of the specified positions cease to exist, then the successor position shall be deemed to be substituted in the place of the former one, and the person holding the successor position shall become an ex officio member of the Committee.
History
(2007-323, s. 6.23(b); 2009-451, s. 27A.5(e); 2010-31, s. 9.12; 2011-145, ss. 6.11(c), 9.4; 2013-360, s. 6.4(d).)
Effect of Amendments. - Session Laws 2009-451, s. 27A.5(e), effective September 1, 2009, substituted "G.S. 105-113.40A" for "G.S. 105-113.41" in subdivision (b)(2).
Session Laws 2010-31, s. 9.12, effective July 1, 2010, in the first paragraph in subsection (c) and in subsection (d), substituted "Chancellor of the University of North Carolina at Chapel Hill" for "President of The University of North Carolina."
Session Laws 2011-145, ss. 6.11(c) and 9.4, effective July 1, 2011, rewrote subdivision (b)(1), which formerly read: "Notwithstanding G.S. 143C-9-3, of the funds credited to the Tobacco Trust Account, the sum of eight million dollars ($8,000,000) is transferred from the Tobacco Trust Account to the University Cancer Research Fund and appropriated for this purpose" and added subsection (g).
Session Laws 2013-360, s. 6.4(d), effective July 1, 2013, rewrote subsection (b).
Legal Periodicals. - For article, "Cancer's IP," see 96 N.C.L. Rev. 297 (2018).
§ 116-29.5: Repealed by Session Laws 2009-209, s. 3, effective June 29, 2009.
Official source: North Carolina General Assembly. Reproduced from public-domain North Carolina statutes; confirm against the official source for the current text. Not legal advice.